News
ARWR ▼ -3.9% - Arrowhead Pharmaceuticals, Inc.
ARWR ▼ -3.9% - Arrowhead Pharmaceuticals, Inc.
$ARWR reported Q4 2026 EPS of -$3.01, missing the -$1.52 estimate by 98.0%. Revenue of $37.8M missed the $61.6M estimate by 38.6%.
12-NOV-2026 04:31 PM ET
Share this post
More filings for $ARWR
ARWR ▼ -4.4% - Arrowhead Pharmaceuticals, Inc.Nov 12, 2026ARWR ▼ -14.2% - Arrowhead Pharmaceuticals, Inc.Nov 9, 2026ARWR ▲ +1.2% - Arrowhead Pharmaceuticals, Inc.Nov 7, 2026ARWR - Arrowhead Pharmaceuticals, Inc. - SEC Filing Update (05-NOV-2026) | ThinkSabio - Stocks SimplifiedNov 5, 2026ARWR ▲ +0.4% - Arrowhead Pharmaceuticals, Inc.Nov 4, 2026ARWR ▲ +0.4% - Arrowhead Pharmaceuticals, Inc.Nov 4, 2026
View full $ARWR filing history →💬 Comments
Loading comments…
Leave a comment